MASLD can be due to obesity with insulin resistance and/or genetic predisposition, i.e., polymorphism in the patatin-like phospholipase domain-containing 3 (PNPLA3) gene. This evidence concerns the gene PNPLA3 and obesity due to melanocortin 4 receptor deficiency.